GetTopicDetailResponse(id=463e88994e4, topicName=血嗜酸性粒細胞, introduction=血嗜酸性粒細胞, content=null, image=null, comments=0, allHits=682, url=https://h5.medsci.cn/topic?id=88994, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=74037, tagList=[TagDto(tagId=74037, tagName=血嗜酸性粒細胞)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2256064, encodeId=866f225606423, content=<a href='/topic/show?id=5a67633069' target=_blank style='color:#2F92EE;'>#Dupilumab#</a> <a href='/topic/show?id=463e88994e4' target=_blank style='color:#2F92EE;'>#血嗜酸性粒細胞#</a>, objectTitle=J Allergy Clin Immunol Pract：Dupilumab對基線血嗜酸性粒細胞≥500/μL的中重度哮喘患兒的療效與安全性, objectType=article, longId=866849, objectId=53c8866849de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241115/1731638883980_8538692.png, objectUrl=/article/show_article.do?id=53c8866849de, replyNumber=0, likeNumber=40, createdTime=2025-03-14, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=53c8866849de, moduleTitle=J Allergy Clin Immunol Pract：Dupilumab對基線血嗜酸性粒細胞≥500/μL的中重度哮喘患兒的療效與安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=53c8866849de)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯話題小助手
2020-05-29
